What parameters are measured by the iSTAT point-of-care analyzer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

iSTAT Point-of-Care Testing Parameters

The iSTAT analyzer measures blood gases (pH, pCO2, pO2), electrolytes (sodium, potassium, chloride, ionized calcium), metabolites (glucose, lactate, urea, creatinine), and hematocrit using single-use cartridges with 65-100 microliters of blood 1, 2.

Core Parameters Available

The specific parameters depend on which cartridge type is used:

Most Common Cartridge Configurations:

  • EC8+ cartridge: Measures sodium, potassium, chloride, urea, glucose, pH, pO2, and pCO2 2
  • EC6+ cartridge: Measures sodium, potassium, ionized calcium, glucose, hematocrit, and pH 2
  • G3+ cartridge: Measures pH, pO2, and pCO2 (blood gases only) 2
  • EG7+ cartridge: Measures pH, pO2, pCO2, sodium, potassium, ionized calcium, and hematocrit 3
  • Creatinine cartridge: Available as separate measurement 2

Additional parameters measured include lactate and total hemoglobin (tHb) on certain cartridge types 4.

Performance Characteristics

The iSTAT demonstrates good analytical performance for most parameters in critically ill patients, with important caveats for specific measurements 1.

Accuracy by Parameter:

  • Excellent precision (CV <2%): Electrolytes, glucose, urea, and pH 2
  • Satisfactory precision (CV <6.5%): Blood gases and creatinine 2
  • Poor precision (CV ~21%): Hematocrit 2

Critical Limitations to Know:

High pO2 values (>10 kPa or ~75 mmHg) show significant deviation from laboratory analyzers and should not be relied upon for clinical decisions in hyperoxic patients 1. The linear trend in deviation becomes problematic when pO2 is between 10-30 kPa (r = -0.59 to -0.61, p <0.001) 1.

Hematocrit measurements can underestimate by up to 2.2% in patients with values below 25%, particularly in non-cardiac ICU populations 1. This discrepancy requires awareness when managing anemic patients.

Creatinine measurements in neonatal blood samples have shown clinically significant discrepancies that can affect management decisions 2. Some institutions have discontinued using the iSTAT creatinine assay for this population.

Pre-analytical Considerations

The device shows significant interference from:

  • Hemolysis: Affects electrolyte measurements (user is notified by flag) 4
  • Benzalkonium: Affects electrolyte measurements (user is notified by flag) 4

No interference occurs from lipemia or methylene blue on co-oximetry results 4.

Clinical Context

Blood gas analyzers like the iSTAT were originally validated in critical care settings for glycemic control protocols 5. The device requires only 2 minutes for analysis and minimal maintenance (2-minute daily electronics check) 6, making it suitable for point-of-care use in critical care units, emergency departments, and operating rooms.

The accuracy established in one patient population cannot be automatically extrapolated to other populations 1, which is why separate validation is essential when implementing iSTAT in different clinical settings (cardiac surgery vs. medical ICU vs. neonatal populations).

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.